The New Antifungal Toolkit 2017: The Pharmacopeia and Beyond

Welcome to This Interactive, Web-Based MSG Education & Research Consortium Activity
The New Antifungal Toolkit 2017: The Pharmacopeia and Beyond

Dear colleague,

Our analysis of MSG-ERC activities reveal that keeping up to date on newer therapies and diagnostics is the number 1 educational need for clinicians who treat invasive mycoses. This latest initiative, The New Antifungal Toolkit 2017: The Pharmacopeia and Beyond, is an Internet CME curriculum that offers 2 planned updates to discussions found in the earlier Toolkit. In this update, we address recent publications related to newer antifungal agents/formulations as well as emerging antifungal agents in the pipeline. We also address the potential impact of newer diagnostics in reducing the trend of spiraling antifungal empiricism, with an eye to antifungal stewardship. We hope you find these updates helpful in your efforts to provide optimal care for patients at risk for or diagnosed with invasive fungal infections.

Regards,

Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA, PhD Hon, FECMM, FAAP

Target Audience
This activity is directed to infectious disease physicians, hematologist/oncologists, critical care physicians, transplant physicians, pathologists, pharmacists, pediatricians, and other healthcare providers responsible for the management of invasive mycoses.

Learning Objectives
At the conclusion of this activity, the participants will be better able to:

·    Evaluate emerging data for newer antifungal agents/formulations

·    Discuss the role of rapid nonculture-based diagnostics in reducing excessive empirical antifungal use

·    Choose appropriate antifungal agents based on patient characteristics

Accreditation Statement
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
The University of Nebraska Medical Center, Center for Continuing Education designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Verification of attendance will be provided to all professionals.

For more information, call 877-276-4523.

No fixed date to begin course
Courses & Workshops